Location History:
- Turnhoutseweg 30 Beerse, BE (2001)
- Turnhout, BE (2001 - 2004)
- Janssen Pharmaceutica N.V., Tumhoutseweg 30, Beerse, 2340, BE (2006)
- Tumhout, BE (2011)
- Lier, BE (2010 - 2018)
Company Filing History:
20 out of 2,079 
2 out of 832,912 Years Active: 2001-2018
Title: **Ludo Edmond Josephine Kennis: Innovator in Pharmaceutical Compounds**
Introduction
Ludo Edmond Josephine Kennis, based in Lier, Belgium, is a remarkable inventor with a strong focus on pharmaceutical innovations. With an impressive portfolio of 22 patents, Kennis has made significant contributions to the field of drug development, particularly in the area of receptor antagonists and PARP inhibitors.
Latest Patents
Kennis' recent patents reflect his expertise in creating novel compounds that address critical medical needs. One of his latest inventions is centered around Quinazolinone derivatives as PARP inhibitors. This invention provides specific compounds identified by a formula, along with their applications as PARP inhibitors and formulation into pharmaceutical compositions. In addition, Kennis has developed Piperidin-4YL-pyridazin-3-ylamine derivatives, which serve as fast-dissociating dopamine 2 receptor antagonists. These compounds are designed to treat or prevent psychotic conditions, including schizophrenia and related disorders, showcasing his commitment to advancing mental health treatments.
Career Highlights
Throughout his career, Ludo Kennis has collaborated with prominent organizations in the pharmaceutical industry. Notably, he has contributed to innovative projects at Janssen Pharmaceutica, where he honed his skills and expanded his knowledge in developing therapeutic compounds. His work has resulted in numerous patent applications, marking him as a notable figure in pharmaceutical research.
Collaborations
Kennis has worked alongside distinguished professionals in the field, including Josephus Carolus Mertens and Maria Victorina Francisca Somers. These collaborations have fostered an environment of innovation and have propelled the development of groundbreaking solutions in the pharmaceutical domain.
Conclusion
With a wealth of patents and a dedication to addressing complex health challenges, Ludo Edmond Josephine Kennis continues to be a significant contributor to pharmaceutical innovations. His work not only reveals the potential of novel compounds but also underscores the importance of collaboration and research in the quest to enhance therapeutic options for patients worldwide.